Neonatal ABG Testing Frequency Optimization via Noninvasive Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Neonates with severe respiratory distress require frequent arterial blood gas (ABG) testing to adjust ventilator settings, but ABG tests are invasive, painful, and costly, necessitating an optimization of testing frequency to minimize pain and cost.
Innovation Solution
A method and system that utilize noninvasive monitoring data, such as blood oxygen saturation and end-tidal carbon dioxide levels, to determine the optimal timing for subsequent ABG tests, adjusting based on the patient's condition and comparing derived values to previous ABG results, with a clinical decision support system recommending test timing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If frequent ABG testing is performed to monitor neonatal respiratory condition, then the reliability of clinical assessment is improved, but the harm to the neonate increases due to pain and cost
Solution Approach 1:
The patent introduces noninvasive monitoring parameters (transcutaneous oxygen and carbon dioxide tension, blood oxygen saturation, respiratory rate) as intermediary indicators that correlate with arterial blood gas values. These intermediaries provide continuous monitoring information without requiring repeated invasive ABG tests, thus maintaining assessment reliability while reducing harm to the neonate
Solution Approach 2:
The system implements continuous feedback monitoring using noninvasive parameters to assess neonatal respiratory status. The feedback loop allows dynamic adjustment of ventilator settings and determines when ABG testing is actually necessary, reducing unnecessary testing while maintaining reliable clinical assessment
2Object-affected harmful factors
If ABG testing frequency is reduced to minimize pain and cost, then the harm to the neonate decreases, but the measurement precision of respiratory status monitoring deteriorates
Solution Approach 1:
The patent implements continuous noninvasive monitoring of respiratory parameters (transcutaneous gases, blood oxygen saturation, respiratory rate) that provides uninterrupted useful information about neonatal respiratory status. This continuous monitoring maintains measurement precision between ABG tests, allowing reduced testing frequency without losing critical information
Solution Approach 2:
The patent replaces the mechanical/invasive ABG testing system with noninvasive monitoring systems (transcutaneous sensors, pulse oximetry, capnography). This substitution maintains monitoring precision while eliminating the pain and costs associated with repeated invasive procedures
3Ease of operation
If noninvasive monitoring is used to reduce testing frequency, then the ease of operation improves, but the device complexity increases due to multiple monitoring systems
Solution Approach 1:
The patent integrates multiple monitoring functions (transcutaneous gas monitoring, pulse oximetry, capnography, respiratory rate monitoring) into a unified system that serves multiple purposes: continuous respiratory status assessment, ventilator management guidance, and ABG testing decision support. This multi-functionality approach manages complexity by making each component serve several roles
4Loss of time
If continuous noninvasive monitoring is implemented to optimize ABG timing, then the loss of time for decision-making is reduced, but the use of energy increases due to continuous data collection and analysis
Solution Approach 1:
The patent implements continuous monitoring but uses algorithmic analysis to determine when full ABG testing is actually necessary versus when noninvasive parameters suffice. This partial action approach processes all the continuous data but only triggers invasive testing or clinician intervention when truly needed, optimizing the balance between timely decision-making and resource utilization
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A system and method for receiving previous arterial blood gas ("ABG") test results for a patient, determining an initial time for a next ABG test for the patient based on the previous ABG test results, receiving monitoring data for the patient and determining a modified time for a next ABG test based on the initial time for the next ABG test and the patient monitoring data.